Kajie Liang

Kajie Liang is a Pharmacy Researcher at Erasmus MC, focusing on pharmacological and clinical research. Her work primarily involves therapeutic drug monitoring, clinical pharmacokinetics, and the study of antipsychotic medications in pediatric and adult populations.

Dr. Liang's research spans several key areas in pharmacology and toxicology. She has a strong focus on therapeutic drug monitoring, particularly for antipsychotic drugs such as risperidone and aripiprazole. Her work also examines the pharmacokinetics of these drugs in children and adolescents, as well as the metabolic effects including weight gain and alterations in appetite-regulating hormones. Additionally, she has contributed to research on frailty in COVID-19 patients and barriers in multi-center drug trials.

Her recent publications (2023-2025) demonstrate a consistent focus on clinical pharmacology, with an emphasis on antipsychotic medications and their effects. She has conducted studies on weight gain and hormonal changes in pediatric patients, case reports on drug intoxication, and reviews on dosing regimens. Her work also extends to geriatric pharmacology, investigating the relationship between frailty and mortality in hospitalized patients.